In this paper the e¡ect of betamethasone valerate solution was compared with that of a UVB comb on scalp psoriasis, both in the healing of lesions and in maintaining the psoriasis in a state of remission.
Evaluation
The scalp psoriasis was graded using a score system taking into consideration erythema, in¢ltration and scaling (PASI score). The response was classi¢ed as``improved'' when more than 50% of the lesions had disappeared, otherwise the designation``unchanged/worse'' was used. Relapses were likewise de¢ned as when more than 50% of the lesions had recurred. The patients were recalled 2 weeks after the end of the treatment for a follow-up evaluation.
Statistical analysis
The absolute changes in PASI score from baseline were compared in both groups using the Wilcoxon one-sample test (p¦0.05).
RESULTS
As can be seen in Table I , 18 of the 22 patients treated with the UVB comb (group A) and all 22 treated with betamethasone valerate (group B) experienced an improvement in their scalp psoriasis. This di¡erence is not statistically signi¢cant. Two weeks after treatment, 11 of the 18 improved patients in group A had relapsed, compared with 19 in group B. This di¡erence, however, is statistically signi¢cant ( pv0.05). Sixteen patients in group A and 17 in group B showed some further improvement 2 weeks after treatment compared with pretreatment levels. The patients' evaluation 2 weeks after treatment correlated well with the objective evaluation made by a dermatologist. No side e¡ects were observed, except that some patients treated with UVB comb had slight xerosis of the scalp.
DISCUSSION
The promising e¡ect of the UVB comb on scalp psoriasis observed during the last few years was con¢rmed and correlated well with an Italian study (1), although we did not obtain a complete remission. The relapses occurred more rapidly in patients treated with betamethasone valerate than in those treated with the UVB comb. Thus this UVB irradiation o¡ers a good alternative to topical corticosteroids.
